Literature DB >> 30233670

Diagnostic value of platelet-derived microparticles in pulmonary thromboembolism: A population-based study.

Minglian Wang1,2, Yingyun Fu1,2, Lan Xu1, Lu Xiao1, Yongjian Yue1,2, Shengguo Liu1, Qijun Huang1, Shulin Li1, Yazhen Li1,2.   

Abstract

An early and accurate diagnosis of pulmonary thromboembolism (PTE) remains challenging. The present study aimed to evaluate the diagnostic value of platelet-derived microparticles in PTE based on a population study. A total of 102 patients with PTE, 102 healthy controls and 40 patients suspected with PTE were enrolled in this study. The platelet count, mean platelet volume and platelet distribution width were assessed using an automated hematology analyzer, P-selectin was assessed using an ELISA kit and PMPs were explored using flow cytometry using Megamix beads. Receiver operating characteristic curves were established to evaluate the diagnostic values of PMPs, D-dimer, PMPs combined with D-dimer, and multiple parameters (including PMPs, platelet distribution width, P-selectin and D-dimer in PTE). The PMP levels were significantly higher in the patients with PTE (609.10/µl) compared with those in the healthy controls (230.60/µl) and patients with suspicious PTE (166.70/µl; P<0.01). The accuracy (72.06%) of PMPs in the diagnosis of PTE was similar to those of D-dimer (P>0.05). The combination of D-dimer and PMPs significantly increased the sensitivity (86.27%) of D-dimer and the specificity of PMP for the diagnosis of PTE (P<0.01). The combination of PMPs, platelet distribution width, P-selectin and D-dimer exhibited high sensitivity (88.24%), specificity (91.18%) and accuracy (89.71%) in the diagnosis of PTE. These findings suggest that elevated PMP levels are an effective predictor of PTE. The combination of PMPs, platelet distribution width, P-selectin and D-dimer may be used in the diagnosis of PTE with high sensitivity and specificity.

Entities:  

Keywords:  D-dimer; platelet-derived microparticles; pulmonary thromboembolism; receiver operating characteristic

Year:  2018        PMID: 30233670      PMCID: PMC6143908          DOI: 10.3892/etm.2018.6579

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  40 in total

1.  The current state of practice in the diagnosis of venous thromboembolism at an academic medical center.

Authors:  Jung-Ah Lee; Brenda K Zierler
Journal:  Vasc Endovascular Surg       Date:  2010-11-11       Impact factor: 1.089

2.  Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expression.

Authors:  Patrícia Napoleão; Maria do Céu Monteiro; Luís B P Cabral; Maria Begoña Criado; Catarina Ramos; Mafalda Selas; Ana Maria Viegas-Crespo; Carlota Saldanha; Miguel Mota Carmo; Rui Cruz Ferreira; Teresa Pinheiro
Journal:  Transl Res       Date:  2015-07-30       Impact factor: 7.012

3.  Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis.

Authors:  Yongzhi Wang; Su Zhang; Lingtao Luo; Eva Norström; Oscar Ö Braun; Matthias Mörgelin; Henrik Thorlacius
Journal:  J Cell Physiol       Date:  2017-06-06       Impact factor: 6.384

4.  D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study.

Authors:  John E Rectenwald; Daniel D Myers; Angela E Hawley; Christopher Longo; Peter K Henke; Kenneth E Guire; Alvin H Schmaier; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2005-12       Impact factor: 5.249

5.  CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.

Authors:  Hisham A E Awad; Azza A G Tantawy; Rania A El-Farrash; Eman A Ismail; Noha M Youssif
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

6.  Circulating microparticles and risk of venous thromboembolism.

Authors:  Paolo Bucciarelli; Ida Martinelli; Andrea Artoni; Serena M Passamonti; Emanuele Previtali; Giuliana Merati; Armando Tripodi; Pier Mannuccio Mannucci
Journal:  Thromb Res       Date:  2011-09-09       Impact factor: 3.944

7.  Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.

Authors:  Eduardo Ramacciotti; Angela E Hawley; Diana M Farris; Nicole E Ballard; Shirley K Wrobleski; Daniel D Myers; Peter K Henke; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

8.  The composition and daily variation of microparticles in whole blood in stable coronary artery disease.

Authors:  Christina Christersson; Bertil Lindahl; Agneta Siegbahn
Journal:  Scand J Clin Lab Invest       Date:  2015-09-25       Impact factor: 1.713

9.  Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.

Authors:  Liangliang Zhao; Yayan Bi; Junjie Kou; Jialan Shi; Daxun Piao
Journal:  J Exp Clin Cancer Res       Date:  2016-03-25

10.  Accuracy of D-dimer:fibrinogen ratio to diagnose pulmonary thromboembolism in patients admitted to intensive care units.

Authors:  Shokoufeh Hajsadeghi; Scott R Kerman; Mojtaba Khojandi; Helen Vaferi; Roza Ramezani; Negar M Jourshari; Sayyed A J Mousavi; Hamidezar Pouraliakbar
Journal:  Cardiovasc J Afr       Date:  2012-09       Impact factor: 1.167

View more
  3 in total

Review 1.  Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence.

Authors:  Olga Porembskaya; Yana Toropova; Vladimir Tomson; Kirill Lobastov; Leonid Laberko; Viacheslav Kravchuk; Sergey Saiganov; Alexander Brill
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

2.  Elevated Microparticles, Thrombin-antithrombin and VEGF Levels in Colorectal Cancer Patients Undergoing Chemotherapy.

Authors:  Marek Z Wojtukiewicz; Marta Mysliwiec; Ewa Sierko; Monika Sobierska; Joanna Kruszewska; Alina Lipska; Piotr Radziwon; Stephanie C Tucker; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  2020-06-24       Impact factor: 3.201

Review 3.  Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.

Authors:  Claudia Cristina Tărniceriu; Loredana Liliana Hurjui; Irina Daniela Florea; Ion Hurjui; Irina Gradinaru; Daniela Maria Tanase; Carmen Delianu; Anca Haisan; Ludmila Lozneanu
Journal:  Medicina (Kaunas)       Date:  2022-02-01       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.